Panacea Innovation

Our Ventures team supports the launch of startups based on University of Michigan technologies and research discoveries. We provide a full suite of resources, services and funding to help you launch sustainable, impactful world changing startups. The Ventures team will engage with you from day one to establish clear and executable commercialization, business formation and funding strategies. As your startup project begins to take form we can provide grant funding and investment capital, as well as business know-how, talent resources and connections to a nationwide network of investors. Whether it is helping you find the perfect team member, investment partner or connecting you with service providers, we have you covered.

Mila Ventures is building the Venture Scientist platform: an integrated venture-creation engine designed to translate frontier AI research into world-class companies - rooted in Canada, built for the world. Mila Ventures operates within Mila, a prestigious AI research institute based in Montréal, founded by Yoshua Bengio, one of the godfathers of modern artificial intelligence and a pioneer of deep learning. The platform brings together: Mila Venture Studio (co-creating companies with professors, students, and entrepreneurs) Mila Accelerator (early company building and scaling) Venture Scientist Academy (training researchers to become venture builders) The Mila Venture Fund (in formation) We operate at the intersection of AI research, venture creation, and capital, working closely with Mila's globally renowned researchers, students, founders, investors, corporate partners, and public institutions.

We invest in opportunities backed by deep science. Xora is an early-stage investment platform of Temasek. We typically invest as a lead or co-lead investor in the Seed and Series A rounds, and later rounds (via our parent company). While we are not limited by geography, we prioritize opportunities that possess a strong linkage with the Singapore science & technology ecosystem. Leveraging the Temasek global network of investors and operating companies, we are active partners to ambitious founders building the next generation of impactful, world-changing companies. Our Team Our team possesses strong technical domain expertise in both physical and life sciences, and the intersection thereof, and are steeped in the nuances of early-stage deep science investing and venture building. We are global citizens with business experience in major markets. Our principles guide our engagement process and our investment decisions.We start with the people on the journey and a shared vision of the future. ​ We look for dogged persistence, unbounded creativity, acute self-awareness, a sense of urgency, and a passion for impact. We embrace both the technical and people complexity of science-based opportunities. ​ We welcome early and frequent contact and appreciate the opportunity to inform an emerging narrative. ​ We prefer brainstorming to pitches, and relationships to transactions. ​ We commit more than capital; we pledge our mindshare and our network.

AdBio partners (formerly Advent France Biotechnology) is a venture capital firm investing in early stage life sciences companies in Europe. AdBio partners’ unique strategy combines early-stage investments in promising startups and strong entrepreneurial support to enable and strengthen the company’s growth. As an early-stage investor, we act as a catalyst to create companies based on innovations coming from academic research. We have established relationships with leading research institutions and technology transfer offices in Europe and benefit from the support of strong network of scientific, clinical, industry and financial partners. The operational team is managed by Alain Huriez, MD, Chairman and Managing Partner, and Geoffroy de Ribains, Managing Partner. The team includes seasoned investment professionals with long-standing track records in entrepreneurial ventures, combined with strong scientific, medical and operational expertise.

We have been in the ecosystem for more than 20 years each. Our Tech Transfer acceleration programmes have accompanied more than 100 spin-offs over these years. We have an ongoing relationship with universities and research centres. Having been entrepreneurs before helps us understand first-hand the challenges faced by our entrepreneurs. Our knowledge of Tech transfer. Our multidisciplinary team of successful entrepreneurs.

The EFL program runs from October – May each year. Founders are not required to have a New York University affiliation and do not have to relocate to New York. The program is free for founders – no equity or fees are taken. Other program benefits include: Executive mentorship: Business leaders, serial entrepreneurs, and seasoned executives will help you craft your company’s vision through time-bound, performance-based goals. Access to leading VCs and Investors: Investment mentors will guide you in successfully raising capital, make connections with New York’s investment community, and may even invest in your startup. Guidance from leading scientists: Prominent scientists and researchers across a myriad of verticals will help you mold your technology development strategy. Business development: NYU Stern’s MBA students will support you in a variety of ways based on your specific business needs. EFL team guidance: The EFL’s expert team will keep you on track to accomplishing your goals by optimizing your access to mentors, MBA students, and other resources throughout the program. Corporate services: EFL’s corporate partners donate many hours and hundreds of thousands of dollars worth of in-kind legal, financial, and technological services. Mentorship from business leaders and scientists Endless Frontier Labs’ mentors are business leaders, investors, and scientists drawn from New York’s thriving business and academic institutions and beyond. Our mentors commit substantial time to provide startups with the best advice and connections to maximize their chances of success. Our ValuesFounder Friendly: We are committed to provide programming in the long-term interests of entrepreneurs. We do not take equity or fees from startups. Each core aspect of the program is in the best interests of founders before, during, and after the program. Inclusivity: We are committed to building an inclusive, equitable, and just community now and for our future. We will provide an environment that is free of bias, prejudice, discrimination, and harassment. Performance Orientation: We are committed to (a) selecting founders with extraordinarily bold, new ideas, (b) providing intimate access to outstanding mentors, and (c) eliciting maximum effort from mentors and founders to accelerate the societal impact of breakthrough science.